Press release
Conversational AI to drive the Intravenous Solutions Market at a CAGR of 10.8%
Persistence Market Research' analysis reveals that in 2022 revenue through the Intravenous Solutions Market is estimated at US$ 12.1 Bn. Worldwide, there has been a growing need for intravenous (IV) solutions. It is crucial because it provides patients in the ICU with the necessary nutrients. Higher efficacy is correlated with a quicker response time. Therapy with intravenous solutions makes a significant contribution to the market's expansion.
Get Sample Copy Of This Report To Understand The Structure Of The Complete Report@ https://www.persistencemarketresearch.com/samples/33231
Companies
Fresenius Kabi
Sino-Swed Pharmaceutical Corp., Ltd
Hospira
Amanta Healthcare
Otsuka Pharmaceutical Co., Ltd
Sichuan Kelun Pharmaceutical Co., Ltd
Terumo Corporation
Baxter
B. Braun Melsungen AG
Claris Lifesciences Ltd
Kyowa Hakko Bio Co., Ltd
Grifols
Liqvor Pharmaceuticals
Sales Analysis of Intravenous Solutions Market from 2017 to 2021 Vs Market Outlook for 2022 to 2032
The global market for the Intravenous Solutions Market expanded at a CAGR of 10% during 2017-2021. As per the Faculty of Health Centre for Rural Health (Australia), more than 75% of patients admitted to hospitals are receiving some type of IV therapy. The United States will continue to be the largest consumer of Intravenous Solutions throughout the analysis period accounting for over US$ 8.8 Bn absolute dollar opportunity in the coming 10-year period.
Region-wise Insights
Why Intravenous Solutions Market in Asia Pacific is Projected to Offer Significant Oppotrunity?
The market in Asia Pacific is projected to register the fastest growth with a projected CAGR of over 11%. China and India account for more than 3.5 Mn preterm births annually, or 24% of all preterm births worldwide. Premature babies are more likely to experience poor growth and illnesses. Therefore, early parenteral nutrition is essential for preterm infants and must provide enough energy and amino acids. This is anticipated to drive the Asia Pacific intravenous (IV) solutions market in the years to come.
To get extensive insights on key trends, request for customization here@ https://www.persistencemarketresearch.com/request-customization/33231
Key Segments Covered in Intravenous Solutions Market Survey
By Type:
Total Parenteral Nutrition (TPN)
Peripheral Parenteral Nutrition (PPN)
By Nutrients:
Carbohydrates
Single Dose Amino Acid Solution
Vitamins & Minerals (Salt and Electrolyte)
Parenteral Lipid Emulsion
Other Nutrients
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/33226
Read More:
https://linkewire.com/2022/12/08/the-intravenous-solutions-market-to-foray-into-digital-innovation-witnessing-a-cagr-of-10-8/#more-221571
Related Reports:
Telemedicine Market
https://www.persistencemarketresearch.com/market-research/telemedicine-market.asp
Robotic Surgery Market
https://www.persistencemarketresearch.com/market-research/robotic-surgery-market.asp
Veterinary Teleradiology Market
https://www.persistencemarketresearch.com/market-research/veterinary-teleradiology-market.asp
Dental Radiology Equipment Market
https://www.persistencemarketresearch.com/market-research/dental-radiology-equipment-market.asp
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Conversational AI to drive the Intravenous Solutions Market at a CAGR of 10.8% here
News-ID: 2858959 • Views: …
More Releases from Persistence Market Research
Antimicrobial Additives Market Expected to Grow at 7.8% CAGR Between 2025 and 20 …
The antimicrobial additives market has evolved into a critical segment within the global specialty chemicals and materials landscape, driven by the growing need to control microbial contamination across healthcare, food packaging, construction, automotive, and consumer goods industries. Antimicrobial additives are incorporated into materials such as plastics, coatings, textiles, and papers to inhibit the growth of bacteria, fungi, and other microorganisms throughout a product's lifecycle. Their role has expanded beyond basic…
Smart Manufacturing Market Valued at US$394.4 Billion in 2025, Expected to Reach …
The smart manufacturing market represents a fundamental transformation in how goods are designed, produced, monitored, and delivered across global industries. It combines advanced digital technologies such as industrial Internet of Things (IIoT), artificial intelligence (AI), machine learning, robotics, cloud computing, digital twins, and advanced analytics to create highly connected, automated, and intelligent production environments. Unlike traditional manufacturing, smart manufacturing enables real-time decision-making, predictive maintenance, adaptive production planning, and end-to-end visibility…
Oligonucleotide Synthesis Market Forecast Signals Strong Expansion During 2025-2 …
The oligonucleotide synthesis market has evolved from a niche research-support function into a strategic pillar of modern biotechnology and pharmaceutical development. Oligonucleotides-short, synthetically produced DNA or RNA sequences-are indispensable in applications ranging from basic genetic research and molecular diagnostics to advanced therapeutics such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and RNA- and DNA-based vaccines. As precision medicine continues to reshape healthcare, the ability to reliably synthesize high-quality, customized…
Genome Editing Market Demand Surges Across Biotechnology and Pharmaceutical Sect …
The genome editing market has emerged as one of the most transformative segments within modern biotechnology, reshaping how scientists, clinicians, and agricultural innovators approach genetic modification. Genome editing refers to a suite of technologies that allow precise alterations to DNA within living organisms, enabling the correction of genetic defects, enhancement of desirable traits, and development of advanced therapeutic solutions. Over the past decade, breakthroughs such as CRISPR/Cas9, base editing, and…
More Releases for Intravenous
Rising Cancer Prevalence Driving The Intravenous Solutions Market: Critical Driv …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Intravenous Solutions Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for intravenous solutions has experienced robust expansion recently and is projected to increase from $14 billion in 2024 to $14.91 billion in 2025, reflecting a compound annual growth rate of 6.5%; this upward…
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market
Soliris Intravenous Market Overview:
The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as…
Intravenous Iron Drugs Market
The "Intravenous Iron Drugs Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Intravenous Iron Drugs Market, 2024-2031
Verified Market Research's most recent report, "Intravenous Iron Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides…
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.
Key Finding
The global Intravenous (IV) Solution market and is expected to reach USD…
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is…
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products.
Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075
Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness…
